AzTrials
AzTrials

Trauma and Stress-related DisordersATICCNCT06922721

Protocol Study on Addiction, Trauma and Immigration Among Vulnerable Young Adults in Grand Est

An observational study of Trauma and Stress-related Disorders and Substance Use Disorder (SUD), run by University of Lorraine at 7 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The ATICC study (Addiction, Trauma, and Immigration, Prevention and Cross-Cultural Support for Care) investigates the complex relationships between trauma, substance use, migration experiences, and mental health perceptions among vulnerable young adults in Transitional Housing (Foyers de Jeunes Travailleurs) in… Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
What is being tested?
Focus group
How many people
182 participants
Where
7 sitesFrance
Study dates
6 Jan 2025to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study population consists of young adults aged 16 to 25 years residing in Transitional Housing for Young Adults (Foyers de Jeunes Travailleurs, FJT) affiliated with the Union Régionale pour l'Habitat des Jeunes (URHAJ). These individuals meet specific vulnerability criteria and come from diverse life trajectories, including those aging out of child welfare services (ASE), individuals under judicial protection (PJJ), persons with disabilities, refugees, and single-parent families. Due to their backgrounds, these young adults face significant adversity, which may have profound effects on their mental health and well-being. This population is particularly exposed to psychosocial stressors, making them a relevant demographic for studying the interplay between trauma, substance use, and mental health care access.

Who may be able to join

  • Resident in a Housing center, speak and read french, adult participants who are not under guardianship or curatorship, any cultural background.

Who cannot join

  • minors, don't speak and read french, adults under guardianship and curatorship.

Trial locations and contacts

7 sites in 1 country. Contact the study team or a site near you to ask about taking part.

7 sites in 1 country

France7 sites, 7 recruiting
  • Les Compagnons du Devoir et du Tour de France

    Jarville-la-Malgrange, 54140

    Foyer de jeunes travailleurs, +33 3 83 57 81 10, mdeliot@compagnons-du-devoir.com

    Maha Najdini, Phd student

    Recruiting
  • Résidence Habitat Jeunes Campus

    Maxéville, 54320

    ADALI-Habitat, +33 3 83 91 10 10, jeandenis.soulis@adali-habitat.fr

    Maha Najdini, Phd student

    Recruiting
  • Association Carrefour

    Metz, 57000

    Association Carrefour, +33 3 87 75 07 26, jerome.zilliox@carrefourmetz.fr

    Maha Najdini, Phd student

    Recruiting
  • Foyer des jeunes ouvriers

    Metz, 57000

    Foyers de jeunes travailleurs, +33 3 87 75 16 41, accueil@fjo-metz.fr

    accueil@fjo-metz.fr

    Recruiting
  • Résidence des Abeilles ADALI-HABITAT

    Nancy, 54000

    Foyer de jeunes travailleurs, +33 3 83 91 10 10, jeandenis.soulis@adali-habitat.fr

    Maha Najdini, Phd student

    Recruiting
  • Résidence MARAE

    Nancy, 54000

    Association AURELIE FINANCE, +33 3 83 39 99 00, nathalie.brot@afinance-asso.fr

    Maha Najdini, Phd student

    Recruiting
  • Habitat Jeunes 3 frontières

    Thionville, 57100

    Foyers de jeunes travailleurs, +33 3 82 53 30 38, m.thiriet@fjt3f.com

    Maha Najdini, Phd student

    Recruiting

Other trials in France

About this study

Official title: ATICC: A Mixed-Methods Study on Addiction, Trauma, and Immigration Among Vulnerable Young Adults in the Grand Est Youth Network

The ATICC study (Addiction, Trauma, and Immigration, Prevention and Cross-Cultural Support for Care) investigates the complex relationships between trauma, substance use, migration experiences, and mental health perceptions among vulnerable young adults in Transitional Housing (Foyers de Jeunes Travailleurs) in France. Using a tripartite methodology, the study includes: (1) a cross-sectional survey to identify risk factors, (2) qualitative interviews to explore individual experiences, and (3) a longitudinal intervention using focus groups to assess psychological well-being and attitudes toward care. The findings will contribute to developing culturally adapted prevention and support programs.

Read the detailed description

The ATICC study (Addiction, Trauma, and Immigration, Prevention and Cross-Cultural Support for Care) is a mixed-methods research project aimed at understanding the interplay between trauma, substance use, migration experiences, and mental health perceptions among vulnerable young adults residing in Transitional Housing for Young Adults (Foyers de Jeunes Travailleurs, FJT) in France. The study will identify key risk factors, assess barriers to healthcare access, and evaluate the effectiveness of group interventions in improving psychological well-being and attitudes toward mental health services.

The study is structured into three complementary research components:

Cross-sectional study: Utilizes standardized questionnaires to assess substance use behaviors, trauma history, mental health status, and barriers to healthcare. The data will be collected at baseline and analyzed using descriptive and multivariate statistical techniques (R software).

Qualitative study: Conducts semi-structured interviews with a subset of participants who engage in substance use. Thematic analysis using NVivo software will be applied to explore individual narratives and subjective experiences related to substance use and mental health perceptions.

Longitudinal interventional study: Implements focus group interventions within transitional housing settings to evaluate their impact on psychological well-being and attitudes toward healthcare. Pre- and post-intervention assessments will be conducted using validated psychological measures.

Data will be analyzed using mixed models and appropriate statistical corrections to assess intervention effectiveness.

Registry procedures and quality factors include a Quality Assurance Plan ensuring data validation, site monitoring, and ethical compliance through adherence to the Committee for the Protection of Persons (CPP) Ile-de-France; Data Checks \& Source Data Verification through automated validation rules and cross-checking against medical records; a Data Dictionary defining all variables, including sources, coding systems (e.g., ICD-10, WHO Drug Dictionary, MedDRA), and reference ranges; and Standard Operating Procedures (SOPs) for participant recruitment, data collection, data management, adverse event reporting, and change management to ensure consistency and compliance. The Sample Size Assessment includes at least 300 participants for the cross-sectional study to ensure statistical power, 40 participants for qualitative interviews to achieve data saturation, and 6-8 participants per focus group session, with repeated measures over six months to track changes. The plan for Missing Data incorporates multiple imputation techniques, sensitivity analyses, and data inconsistency reviews. The statistical analysis plan includes descriptive analyses for mean, median, and standard deviations, and inferential analyses using logistic regression for risk factor identification, mixed-effects models for intervention outcomes, and thematic coding for qualitative data analyzed with NVivo software. Ethical considerations and registration details confirm that the study has received ethical approval from the CPP Ile-de-France (November 18, 2024) and is registered with the French National Agency for the Safety of Medicines and Health Products (ANSM) under ID-RCB: 2024-A01534-43, with participant confidentiality maintained through anonymized data storage and GDPR-compliant procedures. This detailed description provides the necessary technical information on the ATICC study, ensuring compliance with clinical trial registration requirements.

Being tested
Focus group
Keywords
addiction, trauma, Immigration, Mental health, young adults, Substance use
Medical subject headings
Trauma and Stressor Related Disorders, Substance-Related Disorders, Behavior, Addictive, Wounds and Injuries, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focus groupOther

    The "Well-Being Coffee Group" intervention is implemented in two formats: in person and others via videoconference, all facilitated by the same psychologist throughout the study. Across all formats, participation is voluntary and follows an information phase and the signing of an informed consent form. Participants will complete standardized evaluation questionnaires at multiple time points. The discussion groups are designed to create a supportive and open environment that encourages free expression. Their goal is to provide participants with a space to share their thoughts, emotions, and personal experiences, as well as to reflect on those emerging from group discussions. Topics explored include identity, substance use, migratory experiences, and mental health, fostering meaningful dialogue and mutual support.

Study groups in NCT06922721
Study groupRoleWhat they receive
group participantsParticipant aged >18, Resident in a Housing center , Fluent in French, adult participants who are not under guardianship (tutelle) or curatorship (curatelle).
Receives: Other: Focus group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attitudes toward mental health care

    Attitudes toward mental health care is measured through changes in perceptions of mental health services, stigma, and willingness to seek care before and after the intervention through a validated scale.

    Measured: 6 months

Secondary outcomes (5)
  1. Anxiety

    Anxiety is a mental health condition characterized by excessive worry, fear, or nervousness that can interfere with daily functioning. Generalized Anxiety Disorder (GAD) is one of the most common forms assessed using the GAD-7, a self-report screening measure developed to address limitations in existing anxiety assessments. The GAD-7, consisting of seven questions, is widely used in adult primary care and psychiatric settings due to its efficiency, reliability, and sensitivity to treatment-related changes.

    Measured: 6 months

  2. Depression

    Depression is a mood disorder characterized by persistent sadness, loss of interest or pleasure in activities, and other symptoms that interfere with daily life. It can vary in severity and last for weeks, months, or even years. Depression in this study will be assessed using the PHQ-9, a screening tool used to assess the presence and severity of depression. It is based on the nine diagnostic criteria for major depressive disorder from the DSM-IV. Each question in the PHQ-9 assesses a specific symptom of depression and is rated on a scale from 0 to 3, depending on how often the symptom has been experienced in the last two weeks.

    Measured: 6 months

  3. Alcohol use

    Alcohol use will be assessed using the Alcohol Use Disorders Identification Test (AUDIT) to identify individuals with risky or harmful alcohol consumption and detect alcohol dependence.

    The AUDIT questionnaire consists of 10 questions, divided into three categories, alcohol consumption, alcohol-Related problems and signs of alcohol dependence.

    Measured: 6 months

  4. Tobacco use

    Nicotine dependence is going to be assessed the Fagerström test for nicotine dependence that measures the level of nicotine addiction in individuals who smoke cigarettes. Each question is designed to evaluate the degree of nicotine dependence based on smoking behaviors.

    Measured: 6 months

  5. Cannabis use

    Cannabis Abuse Screening Test (CAST) will be used to assess cannabis consumption. It is a six-question tool used to assess problematic cannabis use, and evaluates behaviors linked to cannabis use disorder (CUD), such as frequent consumption, inability to control use, neglect of responsibilities, tolerance, withdrawal symptoms, and continued use despite negative consequences.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2025
  2. Study start6 Jan 2025
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
182 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06922721
Sponsor's protocol ID
2024-A01534-43
Acronym
ATICC
Status last verified
Apr 2025
First submitted
3 Apr 2025
Last updated
10 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We will not share individual participant data (IPD) in order to protect the privacy and confidentiality of our study participants. Our publications will present aggregate findings and summary statistics without revealing any identifiable details.

Publications

  • Najdini M, Frigaux A, Mathieu J, Shadili G, Guenoun T, Vlachopoulou X, Belot RA, Bazan A, Gressier F, Robin M, Essadek A. ATICC: a mixed-methods study on addiction, trauma, and immigration among vulnerable young adults in the grand est youth network. BMC Psychol. 2025 May 30;13(1):582. doi: 10.1186/s40359-025-02738-5.

    PubMed 40448223

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma and Stress-related Disorders and Substance Use Disorder (SUD), run by University of Lorraine at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attitudes toward mental health care (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06922721, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in